ERIKA SIDHU: Open Payments
NPI 1841870284 · REEDLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 30 payments from 7 companies in 2025. Trend: 2023 $300 · 2024 $653 · 2025 $459
Food & beverage: $425Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $167 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| BioCryst US Sales Co., LLC | 1 | $36 |
| Amgen Inc. | 1 | $34 |
| CSL Behring | 2 | $27 |
Products named: TRELEGY ELLIPTA, DUPIXENT, NUCALA, NEFFY, ORLADEYO, Rhapsido, Andembry.
Industry payments across CA — which companies pay providers there.
